Abnormal intracellular Ca 2؉ cycling plays an important role in cardiac dysfunction and ventricular arrhythmias in the setting of heart failure and transient cardiac ischemia followed by reperfusion (I͞R). We hypothesized that overexpression of the sarcoplasmic reticulum Ca 2؉ ATPase pump (SERCA2a) may improve both contractile dysfunction and ventricular arrhythmias. Continuous ECG recordings were obtained in 46 conscious rats after adenoviral gene transfer of either SERCA2a or the reporter gene ␤-galactosidase (␤gal) or parvalbumin (PV), as early as 48 h before and 48 h after 30 min ligation of the left anterior descending artery by using an implantable telemetry system. Sham-operated animals were used for comparison for hemodynamic measurements, whereas within-animal baseline was used for electrocardiographic and echocardiographic parameters. All episodes of nonsustained ventricular tachycardia (VT) and ventricular fibrillation (VF) were counted, and their durations were summed by telemetry. I͞R decreased regional cardiac wall thickening as well as the maximal rate of left ventricular pressure rise (؉dP͞dt) and ventricular pressure fall (؊dP͞dt). SERCA2a restored regional wall thickening and ؉dP͞dt and ؊dP͞dt to levels seen preoperatively. Regionalwall motion and anterior-wall thickening were improved in the SERCA2a animals, as assessed by echocardiography and piezoelectric crystals. To assess whether these effects are SERCA2a specific, we overexpressed a skeletal-muscle protein, PV, to examine whether Ca 2؉ buffering alone can mitigate ventricular arrhythmias. During the first hour after I͞R, the rate of nonsustained VT plus VF was 16 ؎ 5 episodes per h (n ‫؍‬ 6) in the Ad.␤gal group, 22 ؎ 6 in the Ad.PV group, and 4 ؎ 2 (n ‫؍‬ 6, P < 0.01) in the Ad.SERCA2a group. The decrease in VT plus VF in the Ad.SERCA2a group was consistent throughout the 48 h of monitoring. These results show that improving intracellular Ca 2؉ handling by overexpression of SERCA2a restores contractile function and reduces ventricular arrhythmias during I͞R.
T
argeted gene transfer to diseased myocardium has resulted in improvement of ventricular function. These targets included the sarcoplasmic reticulum (SR) Ca 2ϩ AT Pase pump (SERCA2a), survival pathways such as akt, and the ␤ 2 receptors, among others (1) . Over the years, experience with pharmacotherapy has shown that agents that enhance ventricular inotropy in diseased myocardium increase morbidity in terms of decreased survival and increased ventricular arrhythmias (2, 3) . We have shown (4, 5) that gene transfer of SERCA2a is associated with improved ventricular function in an experimental model of heart failure. Unlike pharmacological inotropic agents, however, SERCA2a overexpression was associated with improved survival and enhanced energetic state (4, 5) . An important yet answered issue regarding SERCA2a overexpression is whether increasing SR Ca 2ϩ load would lead to oscillatory Ca 2ϩ release from the SR and worsening arrhythmias. To induce Ca 2ϩ overload acutely, we used a model of ischemia followed by reperfusion (I͞R) in the rat. I͞R in the rat has been studied extensively, and various forms of ventricular arrhythmias [extra beats, ventricular tachycardia (VT), and self-sustained ventricular fibrillation (VF)] have all been documented in this model by continuous telemetry (6) . We investigated the role of SERCA2a and Ca 2ϩ homeostasis in a model of I͞R in rats. We overexpressed SERCA2a in rat hearts and subjected them to I͞R while continuously monitoring their cardiac rhythm by implantable electrocardiographs. To verify that the effects in I͞R are specifically due to SERCA2a overexpression and not just better buffering, we overexpressed PV also, which is a small intracellular, soluble binding protein found exclusively in fast-twitch muscle fibers having an affinity that is intermediate between troponin and SERCA, allowing it to act as a sink. This study allowed us to examine the effects of SERCA2a specifically on arrhythmias in a well documented model of Ca 2ϩ overload.
Methods Adenoviral Vectors.
Recombinant adenoviral vectors were used with cytomegalovirus-driven expression cassettes for SERCA2a (Ad.SERCA2a), parvalbumin (Ad.PV), or ␤-galactosidase (Ad.␤gal) with a second cassette in each adenovirus containing GFP substituted for E1 by means of homologous recombination (7) . Ad.SERCA2a, Ad.PV, and Ad.␤gal had concentrations of 12.0 ϫ 10 11 , 7.0 ϫ 10 11 , and 8.0 ϫ 10 10 pfu͞ml, respectively, with a particle͞pfu ratio of 50:1 and 40:1, respectively. Wild-type adenovirus contamination was excluded by the absence of PCR-detectable E1 sequences.
In Vitro Cardiomyocyte Hypoxia Model. Cardiomyocytes were prepared from 1-to 2-day-old rats, plated on glass coverslip, infected with or without Ad.SERCA2a and subjected to transient hypoxia for up to 24 h, as described (8) . Contraction amplitude, rates of contraction and relaxation, and intracellular calcium transients were recorded online with an edge-detection system and data acquisition (IonOptix, Milton, MA) and analyzed after loading with fura-2 (Molecular Probes), as described (8) , during hypoxia, immediately after reoxygenation, and 2 h after reoxygenation.
Animal Model and Quantification of Arrhythmias. The overall protocol for this study is shown in Fig. 1 . Male 250-to 300-g Sprague-Dawley rats were anesthetized with 60 mg͞kg pentobarbital i.p., intubated, and ventilated (SAR-830; CWE, ArdThis paper was submitted directly (Track II) to the PNAS office.
Abbreviations: I͞R, ischemia followed by reperfusion; SR, sarcoplasmic reticulum; SERCA2a, SR Ca 2ϩ ATPase pump; PV, parvalbumin; ␤gal, ␤-galactosidase; VT, ventricular tachycardia; VF, ventricular fibrillation; ϩdP͞dt, ventricular pressure rise; ϪdP͞dt, ventricular pressure fall; LAD, left anterior descending coronary artery; LV, left ventricular; AAR, area at risk; TTC, triphenyltetrazolium chloride; AP, action potential. more, PA). Two subsets of animals were studied. All animals underwent the following protocols. We injected 200 l of buffer containing either Ad.SERCA2a, Ad.PV, or Ad.␤gal by central thoracotomy into the anteroapical myocardium for 2-6 days before the EKG telemetry implantation and ischemic͞ reperfusion injury. This 2-to 6-day window constitutes the optimal time for gene expression. The telemetry device was implanted by using a hermetically sealed transmitter (7 g, 3 cm
3 ) with a pair of helically wound, flexible stainless-steel wires (diameter, 0.6 mm) insulated with silicone tubing, except for the distal 1-2 cm implanted s.c. (Datasciences, Minneapolis) (Fig.  2) . The transmitter was secured in the abdominal region, and the leads were tunneled under the skin to the recording sites and attached to the underlying tissue to prevent migration. The positive electrode was placed in a Lead II position; the negative electrode was secured over the right scapula. The biopotential signal was digitized, amplified, and continuously emitted with a radiofrequency carrier. Each rat was then housed in an individual cage placed on a receiver that continuously captured the signal, independently of animal activity. After reconversion to analog format and filtering at 100 Hz, a continuous data stream was fed into a personal computer equipped with an analog-todigital converter (AT-MIO-16X, National Instruments, Austin, TX). The data were digitized with 16-bit precision, processed continuously, and displayed in real-time with a sampling rate of 500 Hz. The data were simultaneously stored in a continuous binary data file for later analysis. To induce I͞R, left thoracotomy was again performed, and the left anterior descending coronary artery (LAD) was ligated with 6-0 silk suture 4 mm from its origin with a slipknot. Ischemia was confirmed by myocardial blanching and EKG evidence of injury (Fig. 3) . At 5 min into ischemia, 300 l of fluorescent 10-m FluoSphere microspheres (Molecular Probes) were injected into the left ventricular (LV) cavity. After 30 min, the LAD ligature was released and reperfusion was confirmed visually. For sham I͞R injury, thoracotomy was performed without LAD ligation.
Hemodynamic Measurements. At 24 h after ischemia or sham operation, the first subset of rats underwent thoracotomy and placement of a 1.8F LV pressure transducer (Millar Instruments, Houston). Piezoelectric crystals (0.5-mm; Sonometrics, Ontario) were placed on the anterior epicardial and endocardial LV surfaces. Regional wall thickening (anterior epicardial to endocardial) was calculated from digitally acquired piezoelectric crystal position (Sonometrics). Pressure measurements were digitized at 1.0 kHz and analyzed with commercially available SONOLAB software (Sonometrics) to derive the maximal rates of ventricular pressure rise (ϩdP͞dt) and ventricular pressure fall (ϪdP͞dt).
Echocardiographic Evaluation. Before induction of ischemia and reperfusion, immediately after and 24 h later, wall motion and wall thickening was evaluated on M-mode echocardiography measured from a short-axis view at the level of the papillary muscles. A 128XP͞10c (Acuson, Mountain View, CA) with a 13-Hz probe was used to perform the study.
Infarct Size. Rats were killed 48 h after ischemia. Hearts were sectioned from apex to base into four 1-mm sections by using a blade on a coronal-heart slicer matrix (Braintree Scientific). We used 1-mm sections to quantify the area at risk (AAR) and the infarct area. To delineate the infarct, sections were incubated in 1% (wt͞vol) triphenyltetrazolium chloride (TTC; Sigma) in PBS At 2-6 days before ischemia induction, animals in each group were injected either with buffer or adenovirus carrying the ␤gal, SERCA2a, or PV gene. After 2-6 days, the LAD was ligated for 30 min. At 5 min into the ligation, 400 l of fluorescent mycrospheres were injected into the LV cavity. At 48 h after I͞R, the rats underwent echocardiographic evaluation and hemodynamic measurements using piezoelectric crystals and a pressure catheter. The rats were then killed, and the heart of each animal was excised and sectioned for TTC staining. (pH 7.4) at 32°C for 10 min. The territory of perfused vessels was indicated by the area perfused with red fluorescent microspheres. For each section, the AAR and infarct area were measured from enlarged digital micrographs with IMAGE software (National Institutes of Health, Bethesda). The AAR was defined by the area delineated by the absence of microspheres.
Percentage of myocardial infarction was calculated as the total infarcted area, unstained by TTC, divided by the total AAR for that heart.
Statistical Analysis. Data are presented as mean Ϯ SD. Data were compared by two-tailed t test or ANOVA, as appropriate, with STATVIEW (Abacus Concepts, Berkeley, CA). The null hypothesis was rejected for P Ͻ 0.05.
Results

Survival.
In vivo gene transfer was performed on 46 animals. An overall survival of 80% was obtained in all groups of animals undergoing I͞R. However, both early and late mortality was increased by 50% in the Ad.␤gal and the Ad.PV-treated animals compared with SERCA2a on I͞R injury.
Electrocardiographic Data. Analyses of the baseline recordings before coronary artery occlusion revealed that VT or VF were mainly absent or exceptionally rare in rats without coronary occlusion. During and after coronary occlusion, however, all of the animals developed at least one episode of VT or VF. During ischemia, all groups showed significant ST-segment elevations, as shown in Fig. 3 . As shown in Fig. 4 , the number of episodes of VT and VF increased sharply during ischemia and remained elevated during reperfusion. Both VT and VF were present during this time period (in rats, VF can be self-limited and nonfatal). Most episodes of VT and VF terminated spontaneously, typically followed by a pause and later by a phase of slowly accelerating ventricular-escape rhythm in the presence of various degrees of atrioventricular-conduction block. Overexpression of SERCA2a significantly decreased the number of VT and VF episodes, as shown in Fig. 4 . As shown in Fig. 5 , the number of episodes during the 30 min of occlusion was significantly lower in SERCA2a-overexpressing rats, and similarly, the number of episodes during the first 30 min of reperfusion was significantly lower in SERCA2a-overexpressing rats, as shown in Fig. 5 . Overexpression of PV did not offer any protection from VT or VF during coronary occlusion or reperfusion.
Hemodynamic Measurements. Cardiac function was analyzed at 48 h in a subgroup of animals. The maximal rates of ϩdP͞dt and ϪdP͞dt were reduced significantly by I͞R in control Ad.␤gal rats (Fig. 6 ). Of note, extensive previous physiological measurements have documented that control virus does not affect in vivo cardiac function. SERCA2a overexpression in I͞R, however, significantly increased both ϩdP͞dt and ϪdP͞dt compared with the I͞R plus Ad.␤gal, restoring both to levels seen in sham-operated controls. We also evaluated cardiac-wall motion with piezoelectric crystals placed on the epicardial and endocardial surfaces of the LV anterior wall (Fig. 6 Left). I͞R reduced systolic thickening in the ischemic region in I͞R plus Ad.␤gal, whereas SERCA2a overexpression preserved thickening at levels comparable with sham-operated animals (Fig. 6 ).
Echocardiographic Measurements. Echocardiographic measurement of anterior wall motion and thickness from short-axis views at the level of the papillary muscle revealed a reduced wall motion in the ␤gal-and PV-treated animals and a preserved 6 . Inset shows the method of hemodynamic measurements, with the piezoelectric crystals placed across the anterior wall of the LV and the pressure probe inside the LV cavity, as described previously. To determine cardiac function in vivo, ϩdP͞dt and ϪdP͞dt were derived from measures of LV pressure 24 h after I͞R or sham operation. Ad.SERCA2a prevented decrease in ϩdP͞dt and ϪdP͞dt seen in control animals after I͞R. Anterior systolic thickening was measured by microsonometry with epicardial and endocardial piezoelectric crystals. Ad.SERCA2a expression preserved systolic thickening at levels comparable with sham-operated animals and significantly better than Ad.␤gal transduced animals after I͞R. (SERCA2a, n ϭ 6; ␤gal, n ϭ 8; Sham, n ϭ 7.) function in the SERCA-overexpressing rats (Fig. 7) . A 15% and 13% reduction in anterior-wall thickening in systole was measured in the I͞R plus Ad.␤gal group and I͞R plus Ad.PV groups, respectively, whereas the rat hearts overexpressing SERCA2a rats showed a 4% reduction. Fractional shortening was reduced by 21%, 31%, and 8% in the I͞R plus Ad.PV, I͞R plus Ad.␤gal, and I͞R plus Ad.SERCA2a rats, respectively. Table 1 shows wall-thickness values after I͞R in the Ad.SERCA2a, Ad.␤gal, and Ad.PV groups.
Myocardial Infarction After Ischemia Reperfusion. The ischemic area induced by LAD ligation (%AAR) did not differ among the three groups, as shown in Fig. 8 , in which each representative section of each group shows the extent of infarct with respect to the AAR, as delineated by the distribution of fluorescent beads. A quantification of the average of all section measurements for each heart in the three groups is shown in Fig. 8 . SERCA2a overexpression significantly reduced infarct size compared with the Ad.␤gal-injected group (Fig. 9 ).
Cardiomyocyte Function in Vitro. Given the improvement in cardiac function in vivo, we examined the functional effects of SERCA2a overexpression to transient hypoxia and reoxygenation in vitro. In neonatal cardiomyocytes, hypoxia for 24 h followed by reoxygenation induces prolonged relaxation and impaired calcium uptake into the SR, as shown in Fig. 10 .
Expression of SERCA2a protected from hypoxia͞reoxygen-ation-induced myocyte relaxation abnormality, preserving contractile function and calcium handling comparable to normoxic conditions at immediately after reoxygenation and 2 h after reoxygenation.
Discussion
Ventricular arrhythmias are common events often leading to sudden death in ischemic and nonischemic cardiomyopathy and heart failure (2, 3). We addressed the important issue of whether increasing Ca 2ϩ load would lead to increased oscillatory Ca 2ϩ sparks waves, which worsen arrhythmias and can be prevented by SERCA2a overexpression. To induce Ca 2ϩ overload acutely, we used a rat model of I͞R. I͞R of myocardium induces ventricular arrhythmias including ventricular premature beats, VT and VF in both experimental animal models and in man (9) (10) (11) . Reperfusion of the ischemic myocardium results in an increase in intracellular Na ϩ and Ca 2ϩ (9) (10) (11) . The overload of these ions occurring in myocardial cells appears to be a very important etiologic factor in myocardial injuries (ischemia and heart failure) and arrhythmias. AW, anterior wall; s, systole; d, diastole; PW, posterior wall; FS, fractional shortening. *P ϭ 0.01, compared with SERCA2a. † P ϭ 0.08, compared with SERCA2a. ‡ P ϭ 0.001, compared with SERCA2a. § P ϭ 0.04, compared with SERCA2a. Fig. 7 . The wall motion and wall thickness were evaluated noninvasively before I͞R and 48 h after I͞R in the animal groups treated with Ad.␤gal, Ad.SERCA2a, and Ad.PV. Upper shows the baseline wall movement in M-mode from Ad.␤gal-, Ad.SERCA2a-, and Ad.PV-treated animals. Lower shows the corresponding parameters after I͞R in the same groups. A protection from wall-motion abnormalities corresponding to the invasive measurements was observed in the SERCA2a-treated animals. With reduced ATP in the cell, many ATPase pumps, including SERCA2a, have decreased activity (12) . This reduction in activity results in decreased SR Ca 2ϩ load and elevated diastolic Ca 2ϩ that induce after-depolarizations and triggered activity, culminating in ventricular arrhythmias (11) . Triggered arrhythmias, including delayed after-depolarization (which occur when repolarization is completed and are mostly associated with cellular Ca 2ϩ overload), and early after-depolarizations [which are secondary depolarizations occurring before completion of the action-potential (AP) repolarization] are major initiators of VT and VF and, thus, fatal sudden events (11) .
Under normal conditions, the excitation to contraction coupling is regulated by the sequential changes of ionic currents involved in the balance and timing of the membrane potential and the AP in the specialized pacemaker cells and in the myocytes (11) . Imbalance of timing and activation of these heterogeneous contributors to pacemaker activity lead to arrhythmogenic events. K ϩ channel currents during the AP contribute to the repolarization phase by outward K ϩ currents (I to ), as well as the inward rectifier K ϩ current (I K1 ), which is meant to stabilize the membrane resting potential (E m ) (11) . A reduction in K ϩ currents, as occur in failing hearts, leads to a more positive (depolarized) E m and to triggered activities (early after-depolarizations). The failing myocytes also show a smaller Ca 2ϩ transients that may cause less complete inactivation of the inward Ca 2ϩ current (I Ca ) (physiological trigger of SR Ca 2ϩ release) during the early phases of the AP. Those factors combine to increase the likelihood of reactivation of inward I Ca and early after-depolarizations (11) .
In addition to the reduced K ϩ currents and SERCA2a function, Na ϩ -Ca 2ϩ exchange is increased in failing hearts (13) . This increase in Na ϩ -Ca 2ϩ exchange activity means that a given SR Ca 2ϩ release will produce more activated inward transient current (I ti ) and, thus, more inward Na͞Ca current, leading to more delayed afterdepolarizations. Further, any given I ti will produce a greater delayed after-depolarization because there is less I K1 to stabilize restingmembrane potential. Thus, only half as much SR Ca 2ϩ release is required to cause a delayed after-depolarization that reaches the threshold to trigger an arrhythmogenic AP.
In addition, during ischemia, protons (H overload, induces arrhythmias and cell death.
In our study, we found that SERCA2a overexpression significantly decreased ventricular arrhythmias during I͞R and 24 h later. In addition, SERCA2a overexpression significantly reduced infarct size and improved wall thickening in the anterior wall. The decrease in infarct size may have contributed to the decrease in ventricular arrhythmias because the size of the infarct is associated with the incidence and frequency of arrhythmias. Furthermore, this large decrease in infarct size is most likely due to the survival of cardiomyocytes in the AAR after I͞R. A decrease in diastolic Ca 2ϩ and better handling of intracellular ions during the rush of reperfusion are both associated with improved survival of the cardiomyocyte. The reduced incidence and severity of threatening arrhythmias on I͞R in the SERCA2a-overexpressing animals as compared with I͞R plus Ad.␤gal also correspond to a preservation of muscle function, as shown by improved wall thickening and hemodynamic measurements. To determine whether these effects are specific to SERCA2a or are simply an effect of better buffering, we compared the effects of overexpressing SERCA2a to the effects of overexpressing PV. PV is small (11 kDa) intracellular, soluble Ca 2ϩ binding protein found exclusively in fast-twitch muscle fibers. It has a calcium affinity that is intermediate between troponin and SERCA, allowing it to act as a Ca 2ϩ sink to temporarily bind Ca 2ϩ before SR uptake. PV gene transfer is one approach that has recently been used successfully to target prolonged relaxation in a rodent model of diastolic dysfunction in short term (15) . Adenoviral transduction of PV into the LV free wall has been shown to accelerate LV isovolumic relaxation times significantly in normal animals and also to restore normal relaxation performance in hypothyroidism-induced diastolic dysfunction (15) . However, overexpression of PV in our model did not mitigate the effects of I͞R on contractile dysfunction in the anterior wall, as evidenced by the echocardiographic data, and did not decrease the incidence of arrhythmias. The abrogation of ventricular arrhythmias, therefore, can be specific to SERCA2a overexpression, and this difference may be due to the fact that simply buffering calcium is not sufficient to decrease triggered activity. Furthermore, the large amount of calcium inf lux during I͞R may overwhelm the buffering capacity of PV. Giving that there are multiple ways in which Ca 
